(281)-719-8904 KenFaulkenberry@AAAMP.com

Walgreens Boots Alliance (WBA) Dividend Stock Analysis

by | Dividend Aristocrats, Dividend Champions

Walgreens Boots Alliance Dividend

(updated 2/23/2018)

The Walgreens Boots Alliance (WBA) dividend has been paid since 1972 and increased for 42 consecutive years; qualifying the company as Dividend Aristocrat and Dividend Champion.

Price: $70.34
Dividend Yield: 2.3%

Current Dividend: $1.60
Cash Flow From Operations (CFO) Per Share (ttm): $7.26
Free Cash Flow Per Share (ttm): $5.98

Market Capitalization: $70 B
Enterprise Value: $82 B

Walgreens Store

         Dividend Analyzer Checklist

                                 (updated February 2018)

Valuation Score (24/34 points)

Free Cash Flow Yield (ttm):  8.7% (15/17 points)
EV to EBIT (ttm):  16.3
EV to EBITDA (ttm): 11.4  (9/17 points)
Price to Sales Ratio (ttm): 0.7
Price to Book Value (ttm): 2.6
Price to Earnings Ratio (P/E) (ttm):  19
PE 10: 26

Profitability Score (27/33 points)


Operating Earnings Yield (ttm):  7.5% (11/15 points)
Net Income (ttm): $3845 M
Gross Profit (ttm): $29387 M
Total Assets: $66618 M
Gross Profitability Ratio = GP / Total Assets: 44% (16/18 points)
Cash Return On Invested Capital (CROIC)(tttm): 14%
Return on Invested Capital (ROIC):  8%

 

Dividend Safety Score (24/33 points)

Dividend Payout Ratio (ttm): 42%
Cash Dividend Payout Ratio (ttm): 27%  (11/12 points) 
Net Financial Debt: $12175 M
Total Assets: $66618 M
Net Financial Debt / Total Assets: 18% (8/12 points)
Net Financial Debt to EBITDA (ttm): 237%
Piotroski Score (1-9) (TTM): (5/9 points)

TOTAL POINTS – (75/100) (50 is an average score)

Latest Earnings Report: 1/04/18
Next Earnings Report: 4/05/18

Stay Updated All the Time!

DVB Analyzer Bundle: Dividend Analyzer Newsletter & Dividend Sortable Excel Spreadsheet

DVB Portfolio Bundle: Dividend Portfolio & Treasure Trove Twelve Newsletters

SPECIAL 4 For 1 Price: DVB Full Membership

Learn More

Rankings & Recommendations

(updated February 2018)

Walgreens Boots Alliance (WBA) is ranked #32 (out of 432) overall and #3 (out of 44) in the Consumer Defensive sector by the Dividend Analyzer. WBA has a solid balance sheet and a solid profitability record. The stock should be considered for accumulation on price pull-backs.

Walgreen’s or CVS Health?  For investors trying to decide between the two its basically a toss-up.  If your portfolio needs more healthcare I would favor CVS.  If your portfolio needs more of tilt toward consumer products I would favor WBA.

Type of Investor / Recommendation

Large Diversified Dividend Portfolios / Should Be Considered
Looking For Exposure to Consumer Defensive  Sector /  Should Be Considered
Deep Value Investors /  Should Be Considered

Position Disclosures:
DVB Portfolio Stocks – None
AAAMP Global Value Portfolio – None
AAAMP Retirement Growth & Income Portfolio – None
AAAMP Treasure Trove Twelve Portfolio – None

Description

Sector: Consumer Defensive
Industry: Pharmaceutical Retailers

Walgreens Boots Alliance is the result of the merger of Walgreens and Alliance Boots (Switzerland based) in December 2014. The combined company operates in more that 25 countries and employs more than 370,000 people.

Walgreens has grown both organically and through purchases of competitors, including Rite-Aid in 2015 for 17.2 billion. WBA operates in three segments: Retail Pharmacy USA (70% of revenues), Pharmaceutical Wholesale (20% of revenues), and Retail Pharmacy International (10% of revenues).

SWOT Analysis

Strengths

Walgreens Boots Alliance has at least two important competitive advantages. First, they have tremendous economies of scale due to their size. Acquisitions and mergers have produced significant cost synergies. The ten-year pharmaceutical distribution agreement between Walgreens and AmerisourceBergen should only enhance those advantages.

The second important competitive advantage is strategic assets which are the prime real estate Walgreens owns across the United States. Walgreens has the vast majority of Americans living within a few miles of one of their pharmacies.

The long term outlook for rising prescription use is almost a given. Aging populations, new breakthroughs in drugs, and increasing health care coverage all indicate that demand will be growing for the foreseeable future.

Weaknesses

The retail pharmacy business has consolidated because it is highly competitive. Walgreens and its competitors mostly compete on price and accessibility of store locations. In addition about one-third of profits come from non pharmaceutical products which is also trending to a more competitive environment.

Opportunities

Walgreens size allows it to achieve efficiencies in distribution and costs that smaller retailers are unable to obtain. This is important in a competitive environment. That means WBA will most likely continue to expand through strategic partnerships (i.e. AmerisourceBergin), acquisitions (i.e Rite-Aid) , and mergers (i.e. Boots Alliance).

Threats

Walgreens faces four major threats: 1) Pharmacy Benefits Managers (PBM’s) are customers with huge pricing power. This can keep margins extremely low. 2) The front of the house (non-pharmaceutical products) are experiencing increased competition from various retailers and mass grocers. 3) Changes in Medicare, Medicaid, and Obamacare bring uncertainty. 4) Amazon.

Walgreens Logo
Boots Alliance Store
Pharmacy

Discover, Compare, and Evaluate Dividend Stocks

DVB Analyzer Bundle: Dividend Analyzer Newsletter & Dividend Sortable Excel Spreadsheet - $68/year

DVB Portfolio Bundle: Dividend Portfolio & Treasure Trove Twelve Newsletters - $68/year

SPECIAL 4 For 1 Price: DVB Full Membership: Both Bundles for $99/year

Learn More
Disclaimer: While Arbor Investment Planner has used reasonable efforts to obtain information from reliable sources, we make no representations or warranties as to the accuracy, reliability, or completeness of third-party information presented herein. The sole purpose of this analysis is information. Nothing presented herein is, or is intended to constitute investment advice. Consult your financial advisor before making investment decisions.
Share This